Luca Montini Selected Research

Luca Montini Research Topics

12	Critical Illness (Critically Ill) 05/2023 - 05/2005
7	Infections 07/2020 - 05/2005
6	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 01/2007
5	COVID-19 11/2023 - 01/2021
5	Sepsis (Septicemia) 11/2023 - 12/2016
4	Septic Shock (Toxic Shock Syndrome) 12/2020 - 08/2013
4	Pneumonia (Pneumonitis) 10/2020 - 05/2005
3	Neoplasms (Cancer) 04/2023 - 12/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2021 - 01/2007
2	Hypoxia (Hypoxemia) 01/2021 - 02/2019
2	Acute Kidney Injury (Acute Renal Failure) 12/2020 - 08/2013
1	Hoarseness 03/2024
1	Pharyngitis (Sore Throat) 03/2024
1	Lung Injury 01/2024
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Bacterial Pneumonia 12/2020
1	Brain Injuries (Brain Injury) 11/2019
1	Hypothyroidism 10/2019
1	Atrial Fibrillation 09/2019
1	Hypercapnia 02/2019
1	Dyspnea (Shortness of Breath) 02/2019
1	Intraabdominal Infections 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 12/2017
1	Ventilator-Associated Pneumonia 01/2015
1	Chronic Renal Insufficiency 08/2013
1	Wounds and Injuries (Trauma) 11/2009
1	Hypotension (Low Blood Pressure) 11/2009
1	Hemorrhage 05/2005
1	Bacteremia 05/2005

3	Oxygen (Dioxygen)IBA 01/2022 - 02/2019
3	Tigecycline (Tygacil)FDA Link 07/2020 - 05/2014
2	AminoglycosidesIBA 12/2020 - 08/2013
2	Colistin (Coly-Mycin)FDA Link 01/2017 - 08/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 08/2013
1	Flurbiprofen (Froben)FDA LinkGeneric 03/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	remdesivirIBA 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021
1	tocilizumab (atlizumab)FDA Link 10/2021
1	AntibodiesIBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	CytokinesIBA 10/2021
1	sarilumabIBA 10/2021
1	Dexmedetomidine FDA Link 11/2019
1	Hormones (Hormone)IBA 10/2019
1	Indicators and Reagents (Reagents)IBA 09/2019
1	Carbon DioxideIBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017
1	Ertapenem (Invanz)FDA Link 01/2017
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2017
1	carbapenemaseIBA 01/2017
1	ProcalcitoninIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2016
1	Linezolid (Zyvox)FDA Link 01/2015
1	CreatinineIBA 04/2014
1	GlycopeptidesIBA 08/2013
1	nasIBA 08/2013
1	methanesulfonic acid (methanesulfonate)IBA 08/2013

8	Therapeutics 05/2023 - 01/2019
4	Noninvasive Ventilation 01/2022 - 01/2007
4	Artificial Respiration (Mechanical Ventilation) 01/2021 - 11/2009
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2024 - 01/2007
2	Plasma Exchange 05/2023 - 10/2022
1	Extracorporeal Membrane Oxygenation 11/2023
1	Catheters 01/2023
1	Critical Care (Surgical Intensive Care) 10/2022
1	Mechanical Ventilators (Ventilator) 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2020
1	Central Venous Catheters 09/2019
1	Aftercare (After-Treatment) 02/2019
1	Precision Medicine 01/2019
1	Organ Transplantation 12/2017
1	Traction 11/2009
1	Fracture Fixation 11/2009
1	Blood Transfusion (Blood Transfusions) 05/2005
1	Tracheostomy 05/2005